Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Epilepsy in the elderly].

J J Poza-Aldea1

  • 1Servicio de Neurología, Hospital Donostia, San Sebastian, Guipúzcoa, Spain. jjpoza@chdo.osakidetza.net

Revista De Neurologia
|January 13, 2006
PubMed
Summary
This summary is machine-generated.

For elderly patients with epilepsy, choosing antiepileptic drugs (AEDs) prioritizes favorable pharmacokinetics and minimal side effects. Levetiracetam and pregabalin are recommended first-line treatments due to their safety profiles.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[The importance of adherence to treatment in control of epilepsy].

Revista de neurologia·2024
Same author

[Sleep-related movement and behavioural disorders in adults].

Revista de neurologia·2020
Same author

[Progressive Brown-Sequard syndrome secondary to idiopathic spinal cord herniation: clinico-radiological and surgical correlations].

Revista de neurologia·2020
Same author

[Perampanel as an early added therapy in the treatment of epilepsy].

Revista de neurologia·2019
Same author

[«Apuntes en Neurologia» (Notes in Neurology): a synthesis of the evidence on common paroxysmal neurological disorders and on neurodegenerative disorders].

Revista de neurologia·2018
Same author

[A proposal for a model to replace carbamazepine or oxcarbazepine by eslicarbazepine acetate in clinical practice].

Revista de neurologia·2016
Same journal

The Correlation Between and Variability of Three Balance Scales in the Assessment of Balance Function in Patients With Ataxia.

Revista de neurologia·2026
Same journal

Surgical Treatment of an Aneurysm in the Subacute Stage of Hemorrhagic Moyamoya Disease: Aneurysm Resection Combined With STA-MCA Bypass: A Case Report.

Revista de neurologia·2026
Same journal

Mapping the Evidence: Central Sleep Apnea Syndromes During Sleep and Stroke-A Scoping Review.

Revista de neurologia·2026
Same journal

Developmental and Epileptic Encephalopathy Due to a Novel <i>ARHGEF9</i> Deletion Variant: Case Series of Two Siblings.

Revista de neurologia·2026
Same journal

P300 Event-Related Potentials as Cognitive Biomarkers in Neurological and Neuropsychiatric Disorders: A Systematic Review.

Revista de neurologia·2026
Same journal

[Effectiveness and Risk of Recurrence of Pulsed Radiofrequency in Trigeminal Neuralgia and Chronic Cluster Headache].

Revista de neurologia·2026
See all related articles

Area of Science:

  • Geriatric Medicine
  • Pharmacology
  • Neurology

Context:

  • Epilepsy is common in the elderly, presenting unique etiological, clinical, and prognostic characteristics compared to younger populations.
  • Physiological changes in aging alter drug metabolism, increasing risks of interactions and side effects from antiepileptic drugs (AEDs), especially with polypharmacy.
  • Elderly individuals exhibit heightened sensitivity to AED side effects like cognitive impairment, osteoporosis, and weight gain.

Purpose:

  • To guide the selection of antiepileptic drugs (AEDs) for elderly patients.
  • To emphasize pharmacokinetic profiles and potential side effects over efficacy in AED choice for this demographic.
  • To identify AEDs with favorable safety profiles for geriatric epilepsy management.

Summary:

Related Experiment Videos

  • Levetiracetam and pregabalin demonstrate the most favorable pharmacokinetic profiles for elderly epilepsy patients.
  • Oxcarbazepine and lamotrigine are also considered suitable options.
  • These preferred AEDs generally exhibit limited cognitive effects, do not induce osteoporosis, and (except for pregabalin) do not cause weight gain.

    • Impact:

    • Recommends levetiracetam and pregabalin as first-choice treatments for epilepsy in the elderly.
    • Provides a framework for optimizing AED selection in geriatric patients based on safety and pharmacokinetic considerations.
    • Aims to improve treatment outcomes and reduce adverse events in elderly individuals with epilepsy.